Healius | HLS - 销售成本

股票价格

0.50

每天变化

-0.01 -1.96%

每月一次

-18.70%

每年

-64.29%

Q2 预测

0.51

金融业

AUD

AUD 3.07B

现金及等价物

AUD 60.1M

AUD 218.7M

AUD 1.04B

AUD 804.2M

AUD 1.4B

股息收益率

7.19

AUD 23.7M

AUD 74.9M

8K

EPS每股收益

AUD -0.04

股本和储备

AUD 1.03B

AUD 554.4M

债务利息支出

AUD 32.8M

AUD 1.22B

AUD 363.05M

AUD -12.8M

AUD 684.9M

AUD -22.6M

普通股股本

AUD 2.6B

57.43

AUD -19.2M

AUD 688.1M

销售和管理费用

AUD 393.4M

AUD 31.9M

贸易债权人

AUD 133.9M

应收帐款人

AUD 144.6M

	销售成本	更改		日
Alcidion	AUD 6.82M		1.16M	2025-12
Ansell	USD 605.3M		351.2M	2025-12
Cochlear	AUD 319.2M		160.35M	2025-12
CSL	USD 3.87B		2.08B	2025-12
Fisher Paykel Healthcare	NZD 402.8M		15.2M	2025-12
Integral Diagnostics	AUD 11.53M		146K	2024-06
Mayne Pharma	AUD 43.74M		2.67M	2024-06
Nanosonics	AUD 24.22M		1.11M	2025-12
Polynovo	AUD 9.02M		3.51M	2025-12
Ramsay Health Care	AUD 3.05B		78.7M	2025-12
ResMed	USD 536.28M		21.52M	2025-12
Sigma Healthcare	AUD 1.55B		165.16M	2024-12
Sonic Healthcare	AUD 751.66M		801.13M	2024-12